Anti-dyslipidemic and antioxidant potentials of methanol extract of kalanchoe crenata whole plant in streptozotocin-induced diabetic nephropathy in rats

Tropical Journal of Pharmaceutical Research

Volumn 11, Issue 5, 2012, Pages 767-775

  Fondjo, Foyet Angèle ^a   Kamgang, René ^a,b   Oyono, Jean Louis Essame ^a,b   Yonkeu, Jeanne Ngongang ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Laboratory of Endocrinology and Radioisotopes   (Cameroon)

Author keywords

Antioxidant; Diabetes; Dyslipidemia; Kalanchoe crenata extract; Nephropathy

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; CATALASE; CREATININE; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KALANCHOE CRENATA EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIDYSLIPIDEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; GLUCOSURIA; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; KALANCHOE; KALANCHOE CRENATA; KIDNEY DISEASE; MALE; NONHUMAN; PHYTOCHEMISTRY; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

EID: 84868009743     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Abbate M, Zoja C, Corna D. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular inflammation. J Am Soc Nephrol 1998; 9: 1213-1223.
2. Yokoyama H, Okudaira M, Otani T, Sato A, Miura J, Takaike H, Yamada H, Muto K, Uchigata Y, Ohashi Y, et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int 2000; 58: 302-311.
3. Grover JK, Yadav S, Sats V. Medicinal plants of India anti-diabetic potential. J Ethnopharmacol 2002; 81: 81-100.
4. Diabetes Medicinal Plant Database. (DiaMedBase). in/DMP. 2006. [Cited 2011 Feb 15]. Available from: http://www.progenebio.
5. Dimo T, Fotio LA, Nguelefack TB, Asongalem EA, Kamtchouing P. Anti-inflammatory activity of leaf extracts of Kalanchoe Crenata Andr. Ind J pharmacol 2006; 28: 115-119.
6. Kamgang R, Youmbi Mboumi R, Foyet Fondjo A, Fokam Tagne MA, Mengue N'dille GPR, Ngogang Yonkeu J: Antihyperglycaemic potential of the water-extract of Kalanchoe crenata (crassulaceae). J Nat Med 2008; 62: 34-40.
7. Molle J. Limite de tolérance et toxicité de quelques aminosides (Forme L et DL). Aminopeptidesproteine. Cahier n°4, Ed A.E.C., Paris, 1986.
8. Smith JA, Van den Broek FAR, CantóMartorell J, Hackbarth H, Ruksenas O, Zeller W. Federation of European Laboratory Animal Science Associations: FELASA, Working Group on Ethical Evaluation of Animal Experiments). Principles and practice in ethical review of animal experiments across Europe: summary of the report of a FELASA working group on ethical evaluation of animal experiments. Laboratory Animals 2007; 41: 143-160
9. Friedwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical chemical 1972; 8: 499-502.
10. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal Biochem 1979; 95: 351-358.
11. Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol; 1984; 105: 93-104.
12. Clairbone A. Catalase activity in: RA Greenwald (Ed), CRC Press, Boca Raton, FL; 1985: 283-484.
13. Viau C, Tardif R. Toxicologie. In: environnement et santé publique. Fondements et pratiques. 2003: 119-143.
14. Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year: a histological book to the future. Ann N Y Acad Sci 2000; 899: 136-147.
15. Kurata M, Suzuki M, Agar NS. Antioxidant systems and erythrocyte life span in mammals. Biochemical Physiology 1993; 106: 477-487.
16. Montilla MP, Agil A, Navarro MC, Jimenez MI, Garcia-Granado A, Parra A, Cabo MM. Antioxidant activity of Maslinic acid, a triterpene derivate obtained from olea europaea. Planta Med 2003; 69: 472-474.
17. Harris RC, Neilson EG. Toward a unified theory of renal progression. Ann Rev Med 2006; 57: 365-380.
18. Ohtaket, Kimura M, Nishimura. Roles of reactive oxygen species and antioxidant enzymes in murine daunomycin-Induced nephropathy. J Lab Clin Med 1997; 129: 81-88.
19. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and Ove 26 mice with type 1 diabetes. Diabetes 2006; 55: 2052-2509.
20. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius III FC. Mechanism of glomerulosclerosis in diabetic nephropathy. Diabetes 2008; 57: 1439-1445.